Accurate Clinical Research

AHI has entered into an agreement to carry out clinical testing in Canada for a wide variety of medical conditions in partnership with the licensees of all of the US government’s patents regarding medical cannabis. AHI will become co-patent holders for any and all products that result from this research and will maintain the rights to distribute these products in Canada and elsewhere worldwide.

AHI will initially contract with known clinical experts to evaluate the efficacy of certain strains of MMJ on relieving the pain, reducing symptoms and in some cases actually healing to patient. Some of the conditions to be evaluated include chronic pain from various causes, Parkinson’s disease, dementia, forms of cancer and many others.